Objective: Numerous studies demonstrate the efficacy of antibiotic prophylaxis for reducing postcesarean section infectious morbidity. The duration of therapy, however, remains controversial.
cesarean section infectious morbidity. Controversy regarding the duration of therapy and cost containment measures have led to the introduction of "extended" half-life (tl/2) agents for single-dose use.
Since, in order to be effective, a prophylactic agent only needs to be present at the time of bacterial contamination, 2 we tested the hypothesis that there was no difference in efficacy between a short halflife agent (cefoxitin: l/2 41-59 min) and a longerlife agent (cefotetan: t/2 180-276 min). These 2 agents have a similar antibacterial spectrum and are both recommended to reduce infectious morbidity after cesarean section. 3 examinations. However, a significant reduction in morbidity was noted in the cefoxitin group compared with the cefotetan group for those subjects having surgeries lasting <60 rain (P 0.01), primary cesarean section (P 0.03), and having ruptured membranes <7 h duration (P 0.01). 
